大幸薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2015/11/06 | 1,835 | 1,848 | 1,815 | 1,848 | +11 | +0.6% | 54,900 |
| 2015/11/05 | 1,797 | 1,856 | 1,795 | 1,837 | +45 | +2.5% | 96,600 |
| 2015/11/04 | 1,846 | 1,875 | 1,792 | 1,792 | -63 | -3.4% | 144,600 |
| 2015/11/02 | 1,899 | 1,899 | 1,841 | 1,855 | -49 | -2.6% | 83,800 |
| 2015/10/30 | 1,897 | 1,907 | 1,858 | 1,904 | +12 | +0.6% | 104,300 |
| 2015/10/29 | 1,869 | 1,897 | 1,867 | 1,892 | +16 | +0.9% | 118,900 |
| 2015/10/28 | 1,873 | 1,886 | 1,863 | 1,876 | +2 | +0.1% | 35,000 |
| 2015/10/27 | 1,894 | 1,896 | 1,871 | 1,874 | -17 | -0.9% | 37,200 |
| 2015/10/26 | 1,897 | 1,904 | 1,875 | 1,891 | +19 | +1% | 52,200 |
| 2015/10/23 | 1,880 | 1,880 | 1,850 | 1,872 | +6 | +0.3% | 45,400 |
| 2015/10/22 | 1,888 | 1,895 | 1,863 | 1,866 | -29 | -1.5% | 35,600 |
| 2015/10/21 | 1,879 | 1,905 | 1,876 | 1,895 | +4 | +0.2% | 60,000 |
| 2015/10/20 | 1,901 | 1,907 | 1,879 | 1,891 | -8 | -0.4% | 36,000 |
| 2015/10/19 | 1,901 | 1,905 | 1,890 | 1,899 | +7 | +0.4% | 33,800 |
| 2015/10/16 | 1,900 | 1,925 | 1,887 | 1,892 | -1 | -0.1% | 92,000 |
| 2015/10/15 | 1,859 | 1,898 | 1,855 | 1,893 | +37 | +2% | 49,000 |
| 2015/10/14 | 1,899 | 1,899 | 1,849 | 1,856 | -33 | -1.7% | 61,700 |
| 2015/10/13 | 1,893 | 1,917 | 1,889 | 1,889 | +9 | +0.5% | 79,700 |
| 2015/10/09 | 1,857 | 1,899 | 1,857 | 1,880 | +15 | +0.8% | 135,800 |
| 2015/10/08 | 1,855 | 1,879 | 1,826 | 1,865 | +10 | +0.5% | 70,700 |
| 2015/10/07 | 1,816 | 1,857 | 1,814 | 1,855 | +13 | +0.7% | 84,500 |
| 2015/10/06 | 1,840 | 1,863 | 1,813 | 1,842 | +82 | +4.7% | 227,500 |
| 2015/10/05 | 1,738 | 1,776 | 1,738 | 1,760 | +35 | +2% | 84,000 |
| 2015/10/02 | 1,697 | 1,730 | 1,695 | 1,725 | +16 | +0.9% | 61,200 |
| 2015/10/01 | 1,713 | 1,715 | 1,688 | 1,709 | +7 | +0.4% | 47,500 |
| 2015/09/30 | 1,700 | 1,713 | 1,680 | 1,702 | +12 | +0.7% | 45,200 |
| 2015/09/29 | 1,702 | 1,734 | 1,688 | 1,690 | -46 | -2.6% | 86,500 |
| 2015/09/28 | 1,709 | 1,746 | 1,698 | 1,736 | +36 | +2.1% | 66,800 |
| 2015/09/25 | 1,674 | 1,713 | 1,674 | 1,700 | +27 | +1.6% | 50,200 |
| 2015/09/24 | 1,671 | 1,698 | 1,670 | 1,673 | -7 | -0.4% | 49,300 |
| 2015/09/18 | 1,676 | 1,686 | 1,672 | 1,680 | -3 | -0.2% | 56,700 |
| 2015/09/17 | 1,680 | 1,693 | 1,674 | 1,683 | +4 | +0.2% | 29,500 |
| 2015/09/16 | 1,697 | 1,699 | 1,672 | 1,679 | +3 | +0.2% | 32,700 |
| 2015/09/15 | 1,691 | 1,718 | 1,674 | 1,676 | -25 | -1.5% | 84,600 |
| 2015/09/14 | 1,714 | 1,756 | 1,701 | 1,701 | -7 | -0.4% | 74,200 |
| 2015/09/11 | 1,700 | 1,727 | 1,681 | 1,708 | -1 | -0.1% | 132,100 |
| 2015/09/10 | 1,667 | 1,721 | 1,662 | 1,709 | +13 | +0.8% | 119,100 |
| 2015/09/09 | 1,677 | 1,696 | 1,671 | 1,696 | +45 | +2.7% | 93,800 |
| 2015/09/08 | 1,685 | 1,690 | 1,650 | 1,651 | -29 | -1.7% | 88,700 |
| 2015/09/07 | 1,671 | 1,692 | 1,667 | 1,680 | -20 | -1.2% | 67,700 |
| 2015/09/04 | 1,688 | 1,705 | 1,670 | 1,700 | +9 | +0.5% | 94,600 |
| 2015/09/03 | 1,697 | 1,703 | 1,673 | 1,691 | +5 | +0.3% | 108,300 |
| 2015/09/02 | 1,660 | 1,715 | 1,660 | 1,686 | +11 | +0.7% | 113,100 |
| 2015/09/01 | 1,720 | 1,720 | 1,672 | 1,675 | -45 | -2.6% | 133,800 |
| 2015/08/31 | 1,739 | 1,745 | 1,711 | 1,720 | +5 | +0.3% | 131,200 |
| 2015/08/28 | 1,741 | 1,741 | 1,708 | 1,715 | +10 | +0.6% | 164,200 |
| 2015/08/27 | 1,750 | 1,759 | 1,700 | 1,705 | -8 | -0.5% | 200,200 |
| 2015/08/26 | 1,719 | 1,727 | 1,661 | 1,713 | +27 | +1.6% | 203,400 |
| 2015/08/25 | 1,790 | 1,827 | 1,683 | 1,686 | -145 | -7.9% | 326,400 |
| 2015/08/24 | 1,829 | 1,891 | 1,805 | 1,831 | -57 | -3% | 305,800 |
2351～
2400
件表示中 / 3978件
類似銘柄と比較する
現在ご覧いただいている「大幸薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 大幸薬品 | 36,700円 | +0.1% | -70.9% | 0.00% | 61.37倍 | 2.31倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
| ステムリム | 32,600円 | - | - | 0.00% | - | 3.00倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 扶桑薬 | 210,200円 | +1.6% | -12.7% | 4.28% | 7.81倍 | 0.54倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ＣＡＮＢＡＳ | 96,600円 | - | - | 0.00% | - | 6.18倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| キッズバイオ | 37,000円 | - | - | 0.00% | - | 13.17倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞（ＳＨＥＤ）用いた再生医療に力 |
市場注目の銘柄
チャート関連のコラム
